Emerging drugs for complicated skin and skin-structure infections.
IMPORTANCE OF THE FILED: With the worldwide surge of MRSA, skin and skin-structure infection (SSTI) treatment has become a challenge for physicians. Cultures and antibiotic susceptibility tests for SSTIs are the rule due to the implication in morbidity and mortality rates associated with MRSA infections. The need for new antibiotics is evident and the effort to decrease antibiotic resistance is a world priority.


METHODS
This manuscript accesses the actual treatments and the developing of antibiotics for MRSA SSTIs.


RESULTS
This is a review of the data on the available and emerging treatments for MRSA SSTIs.


CONCLUSIONS
There is an unmet medical need for new antibiotics in the new millennium. As physicians, we must assure all appropriate procedures are completed in order to reduce the bacterial resistance, especially for MRSA.
Mendoza
Natalia
N
Center for Clinical Studies, 6655 Travis Suite 120, Houston, TX 77030, USA. nmendoza@ccstexas.com
Tyring
Stephen K
SK
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D016106:Methicillin Resistance; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D008826:Microbial Sensitivity Tests; D018461:Soft Tissue Infections / Q000188:drug therapy* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013207:Staphylococcal Skin Infections / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents